{"id":"W4396237921","doi":"10.1016/j.biopsych.2024.02.031","title":"Navacaprant, a Novel Kappa Opioid Receptor Antagonist for Major Depressive Disorder: A Randomized Placebo-Controlled Phase 2 Trial","year":2024,"lang":"en","type":"article","venue":"Biological Psychiatry","topic":"Treatment of Major Depression","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"Placebo; Kappa; κ-opioid receptor; Antagonist; Medicine; Randomized controlled trial; Opioid; Pharmacology; Internal medicine; Opioid receptor; Psychology; Psychiatry; Receptor; Mathematics; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001532162,0.002268015,0.003270513,0.0004075885,0.0004931697,0.001085568,0.000957392,0.002104229,0.009137602],"category_scores_gemma":[0.001857625,0.0007362888,0.001826046,0.0004563592,0.001114535,0.001207926,0.0003296979,0.003170854,0.001143766],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007293886,"about_ca_system_score_gemma":0.001022022,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001616772,"about_ca_topic_score_gemma":0.004161414,"domain_scores_codex":[0.9994938,0.0002313751,0.00003076601,0.0001109661,0.00004155398,0.00009149609],"domain_scores_gemma":[0.999363,0.0002078826,0.0001262287,0.00004961473,0.00005132121,0.0002019392],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9736544,0.003396798,0.0003780502,0.001147833,0.001331994,0.00004681044,0.00004496645,0.0001993057,0.002708582,0.0001589329,0.001345455,0.01558693],"study_design_scores_gemma":[0.9793462,0.01876838,0.0006838577,0.00002731987,0.0003614248,0.00002460727,0.00001324837,0.0001341712,0.0001071881,0.00008468875,0.0004400314,0.000008942812],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9516215,0.02555061,0.002051087,0.002111178,0.002071674,0.008232675,0.00281616,0.0004391315,0.00510605],"genre_scores_gemma":[0.9599494,0.01541896,0.003173971,0.003212469,0.001176361,0.007274545,0.002210308,0.00006665538,0.007517287],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009137602,"threshold_uncertainty_score":0.0305683,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02570506390768588,"score_gpt":0.3352346645322092,"score_spread":0.3095296006245233,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}